Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA All news Official partner of the Eurovision Song Contest 2025 Between May 10-17, 2025, Basel will host the Eurovision Song Contest and we are excited to be an official par...
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA All news Official partner of the Eurovision Song Contest 2025 Between May 10-17, 2025, Basel will host the Eurovision Song Contest and we are excited to be an official par...
Animal research is governed by our animal welfare policy. Clinical trials transparency Providing information on clinical trials and their results serves everyone including study participants, patients and healthcare providers. ESG rating performance
Welcome to where we thrive together Working together. Learning together. Thriving together. Discover how you can join us in changing people's lives. Join us Resource links About Novartis Healthcare professionals Patients and caregivers Pipeline ...
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition). U.S. National Library of Medicine: Clinical Trials. ...
6.5 Clinical Study Experience in Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex 6.6 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Agents That May Increase Everolimus Blood Concentrations 7.2 Agents That May Decrease Everolimus Blood Concentrations ...
1.Gleevec. Prescribing information. Novartis Pharmaceuticals Corp. 2.Pubmed. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=gleevec Accessed August 16, 2023. 3.ClinicalTrials.gov. Available at https://clinicaltrials.gov/ct2/results/map?term=IMATINIB+MESYLATE&map Accessed August 16, 2023...
“momentum,” or similar expressions, or by express or implied discussions regarding potential new products, potential new indications for existing products, potential product launches, or regarding potential future...
The 28 transaction also includes two additional pre-clinical pro- grams for other neuroscience indications. The transac- tion closed on July 14, 2023. The purchase price consisted of a cash payment of USD 0.6 billion and potential additional milestones of up to USD 0.5 billion, which the...
To assess preliminary clinical antitumor activity in Arms 1, 2, and 3. Study Design (FIG.23) In the Phase Ib portion of this multicenter, open-label study, postmenopausal women with ER+/human epidermal growth factor receptor negative (HER2-) advanced BC are being treated with once-daily dos...